Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Status Recruiting

Clinical Trial Summary

Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking. The specific aims of are to: UG3: Aim 1. Examine the burden of tobacco use and its influence on pulmonary health disparities (lung cancer, COPD, and asthma) in the patient population and the economically disadvantaged and racially segregated catchment areas of Mile Square Health Centers. Aim 2: Evaluate among MSHC patients and health care providers, knowledge, attitudes, barriers and facilitators related to smoking cessation, engagement with the tobacco quit line, linkage to the tobacco quit line via a patient health portal and receipt of patient navigation to facilitate access to the tobacco quit line. Aim 3: Evaluate the use of community engagement strategies to increase uptake of the UI Health Patient Portal among low-income patients receiving care at Mile Square Health Center. Aim 4: Test the acceptability, feasibility, and capacity of Mile Square Health to deliver Mi Quit CARE, an evidence-based and multi-level intervention to increase engagement with the quit line via the UI Health Portal. UH3: Aim 1: Determine the effectiveness Mi Quit CARE compared to standard of care in increasing patient engagement with the Illinois tobacco quitline and subsequent smoking cessation outcomes. Aim 2: Evaluate the scalability of Mi Quit CARE to multiple sites within the UI Health FQHC Mile Square clinic network and by translating the intervention to Spanish. Aim 3: Examine the cost effectiveness of Mi Quit CARE on smoking cessation outcomes compared to standard of care among a high risk FQHC population.

Clinical Trial Description

A detailed description can be found at :Matthews, A. K., Watson, K. S., Duangchan, C., Steffen, A., & Winn, R. (2021). A Study Protocol for Increasing Access to Smoking Cessation Treatments for Low-Income Minority Smokers. Frontiers in Public Health, 9, 762784 ;

Study Design

Related Conditions & MeSH terms

Tobacco Use Cessation

Clinical Trial Details

NCT number	NCT04827420
Study type	Interventional
Source	University of Illinois at Chicago
Contact	Alicia Matthews, Phd
Phone	3129967885
Email	aliciak@uic.edu
Status	Recruiting
Phase	N/A
Start date	September 1, 2021
Completion date	August 1, 2027

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06021652` - Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening	N/A
Completed	`NCT02735382` - EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study	N/A
Completed	`NCT02557919` - Families Reduce Exposure to Smoke at Home	N/A
Completed	`NCT01570595` - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV	Phase 1/Phase 2
Completed	`NCT00786149` - Improving Varenicline Adherence and Outcomes in Homeless Smokers	Phase 3
Completed	`NCT00387946` - Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)	Phase 3
Completed	`NCT00218452` - Smoking Cessation for Young Adults Who Binge Drink - 1	Phase 0
Completed	`NCT00124683` - Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1	Phase 2
Recruiting	`NCT04610931` - Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation	N/A
Enrolling by invitation	`NCT06042361` - Enhancing Equity in Smoke-free Housing	N/A
Recruiting	`NCT04994444` - Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts	Phase 2/Phase 3
Completed	`NCT05560243` - Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil	N/A
Completed	`NCT02721082` - Changing the Default for Tobacco Treatment	Phase 4
Completed	`NCT01885221` - A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)	N/A
Completed	`NCT03445507` - Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.	N/A
Completed	`NCT04540081` - Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer	N/A
Completed	`NCT03714191` - Optimizing the Tobacco Cessation Clinical Decision Support Tool.
Completed	`NCT03553992` - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers	N/A
Completed	`NCT01699828` - Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET	Phase 1/Phase 2
Completed	`NCT01328431` - Treating Low-Income Smokers in the Hospital Emergency Department	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.